niceritrol has been researched along with Nephrotic Syndrome in 2 studies
Niceritrol: An ester of nicotinic acid that lowers cholesterol and triglycerides in total plasma and in the VLD- and LD-lipoprotein fractions.
Nephrotic Syndrome: A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The authors treated a 36-year-old woman with LPG and exhibiting a nephrotic syndrome using an intensive lipid-lowering therapy consisting of fenofibrate (300 mg), niceritrol (750 mg), ethyl-icosapentate (1,800 mg), and probucol (500 mg)." | 3.72 | Resolution of typical lipoprotein glomerulopathy by intensive lipid-lowering therapy. ( Hotta, O; Ieiri, N; Taguma, Y, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamatani, H | 1 |
| Hiromura, K | 1 |
| Kobatake, K | 1 |
| Yoshida, H | 1 |
| Kobayashi, S | 1 |
| Yoneda, N | 1 |
| Kayakabe, K | 1 |
| Matsumoto, T | 1 |
| Kuroiwa, T | 1 |
| Ueki, K | 1 |
| Nojima, Y | 1 |
| Ieiri, N | 1 |
| Hotta, O | 1 |
| Taguma, Y | 1 |
2 other studies available for niceritrol and Nephrotic Syndrome
| Article | Year |
|---|---|
Successful treatment of lipoprotein glomerulopathy in a daughter and a mother using niceritrol.
Topics: Adolescent; Apolipoproteins E; Child; Child, Preschool; Female; Humans; Kidney Glomerulus; Middle Ag | 2010 |
Resolution of typical lipoprotein glomerulopathy by intensive lipid-lowering therapy.
Topics: Adult; Anticholesteremic Agents; Apolipoproteins E; Drug Combinations; Eicosapentaenoic Acid; Female | 2003 |